3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Breast Neoplasms
96
Carcinoma, Non-Small-Cell Lung
85
Prostatic Neoplasms
75
Multiple Myeloma
74
Neoplasms
50
Leukemia, Myeloid, Acute
44
Lymphoma
43
Melanoma
42
Neoplasm Metastasis
39
Ovarian Neoplasms
37
Squamous Cell Carcinoma of Head and Neck
35
Lymphoma, Non-Hodgkin
34
Lung Neoplasms
34
Leukemia, Lymphocytic, Chronic, B-Cell
32
Hematologic Neoplasms
29
Colorectal Neoplasms
29
Triple Negative Breast Neoplasms
27
Hodgkin Disease
24
Pancreatic Neoplasms
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Myelodysplastic Syndromes
21
Fallopian Tube Neoplasms
21
Carcinoma, Renal Cell
21
Sarcoma
20
Lymphoma, Follicular
20
Urinary Bladder Neoplasms
18
Recurrence
18
Lymphoma, Mantle-Cell
18
Head and Neck Neoplasms
18
Brain Neoplasms
18
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Nerve Tissue
×
90 days
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts